Order Total (1 Item Items):
Shipping Destination:
Anticancer Drug Development Guide (41 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (41)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (31)
- As New, Fine or Near Fine (3)
- Very Good or Good (6)
- Fair or Poor (1)
- As Described (No further results match this refinement)
Binding
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (14)
- Not Print on Demand (30)
Language (1)
Free Shipping
Seller Location
Seller Rating
-
hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
-
Hardcover. Condition: Very Good. DVD unused. Very Good. Used with some reading wear but is still in great reading condition. No markings in text.
-
Condition: Good. Ships SAME or NEXT business day. We Ship to APO/FPO addr. Choose EXPEDITED shipping and receive in 2-5 business days within the United States. See our member profile for customer support contact info. We have an easy return policy.
-
Hardcover. Condition: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less.
-
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
Book 2 of 96: Cancer Drug Discovery and DevelopmentSeller: Wonder Book, Frederick, MD, U.S.A.
Seller rating 5 out of 5 stars
Condition: Good. Good condition. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains.
-
hardcover. Condition: Very Good. Ships Out Tomorrow!
-
Hardcover. Condition: Very Good. Dust Jacket Condition: No Dust Jacket. Second Edition; First Printing. A tight and clean copy. Light rubbing and toning overall. Interior pages clean and unmarked. Photos upon request. International shipping billed at cost.; Cancer Drug Discovery And Development; Large 8vo 9" - 10" tall; 465 pages.
-
hardcover. Condition: Sehr gut. 465 Seiten; 9781588292285.2 Gewicht in Gramm: 2.
-
-
hardcover. Condition: New. In shrink wrap. Looks like an interesting title!
-
Condition: New. Satisfaction Guaranteed or your money back.
-
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
Book 2 of 96: Cancer Drug Discovery and DevelopmentSeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 94.30
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Anticancer Drug Development Guide
Book 2 of 96: Cancer Drug Discovery and DevelopmentSeller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Seller rating 5 out of 5 stars
Condition: New. Editor(s): Teicher, Beverly A. Series: Cancer Drug Discovery & Development. Num Pages: black & white illustrations, bibliography. BIC Classification: MJCL; MMG. Category: (G) General (US: Trade). Dimension: 254 x 178 x 18. Weight in Grams: 572. . 2013. Paperback / so. . . . .
-
Condition: New. Editor(s): Teicher, Beverly A. Series: Cancer Drug Discovery & Development. Num Pages: black & white illustrations, bibliography. BIC Classification: MJCL; MMG. Category: (G) General (US: Trade). Dimension: 254 x 178 x 18. Weight in Grams: 572. . 2013. Paperback / so. . . . . Books ship from the US and Ireland.
-
Taschenbuch. Condition: Neu. Anticancer Drug Development Guide | Preclinical Screening, Clinical Trials, and Approval | Beverly A. Teicher | Taschenbuch | xii | Englisch | 2013 | Humana | EAN 9781461581543 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Anticancer Drug Development Guide
Book 2 of 96: Cancer Drug Discovery and DevelopmentLanguage: English
Published by Humana Press, Humana Press Jun 2013, 2013
ISBN 10: 1461581540 ISBN 13: 9781461581543
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. Neuware -Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval. They focus on using preclinical in vivo and in vitro methods to identify molecules of interest, detailing the targets and criteria for success in each type of testing and defining the value of the information obtained from the various tests. They also define each stage of clinical testing, explain the criteria for success, and outline the requirements for FDA approval. A companion volume by the same editor (Cancer Therapeutics: Experimental and Clinical Agents) reviews existing anticancer drugs and potential anticancer therapies. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for the present and the future of the field.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 328 pp. Englisch.
-
Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Anticancer Drug Development Guide
Book 22 of 96: Cancer Drug Discovery and DevelopmentSeller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Seller rating 5 out of 5 stars
Condition: New. Editor(s): Teicher, Beverly A.; Andrews, Paul A. Series: Cancer Drug Discovery and Development. Num Pages: 451 pages, 161 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 24. Weight in Grams: 883. . 2012. Softcover reprint of the original 1st ed. 2004. Paperback. . . . .
-
Taschenbuch. Condition: Neu. Anticancer Drug Development Guide | Preclinical Screening, Clinical Trials, and Approval | Paul A. Andrews (u. a.) | Taschenbuch | xiv | Englisch | 2012 | Humana Press | EAN 9781468498417 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Anticancer Drug Development Guide
Book 22 of 96: Cancer Drug Discovery and DevelopmentLanguage: English
Published by Humana Press, Humana Press Aug 2012, 2012
ISBN 10: 146849841X ISBN 13: 9781468498417
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. Neuware -This unique volume traces the critically important pathway by which a 'molecule' becomes an 'anticancer agent. ' The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink malignant tumor masses for relatively substantial periods of time gave great impetus to the search for molecules that would be lethal to specific cancer cells. Weare still actively engaged in that search today. The question is how to discover these 'anticancer' molecules. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Second Edition describes the evolution to the present of preclinical screening methods. The National Cancer Institute's high-throughput, in vitro disease-specific screen with 60 or more human tumor cell lines is used to search for molecules with novel mechanisms of action or activity against specific phenotypes. The Human Tumor Colony-Forming Assay (HTCA) uses fresh tumor biopsies as sources of cells that more nearly resemble the human disease. There is no doubt that the greatest successes of traditional chemotherapy have been in the leukemias and lymphomas. Since the earliest widely used in vivo drug screening models were the murine L 1210 and P388 leukemias, the community came to assume that these murine tumor models were appropriate to the discovery of 'antileukemia' agents, but that other tumor models would be needed to discover drugs active against solid tumors.Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 468 pp. Englisch.
-
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval (Cancer Drug Discovery and Development)
Book 22 of 96: Cancer Drug Discovery and DevelopmentSeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 184.60
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Paperback. Condition: Brand New. reprint edition. 465 pages. 9.75x7.00x1.25 inches. In Stock.
-
Condition: New. Editor(s): Teicher, Beverly A.; Andrews, Paul A. Series: Cancer Drug Discovery and Development. Num Pages: 451 pages, 161 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 24. Weight in Grams: 883. . 2012. Softcover reprint of the original 1st ed. 2004. Paperback. . . . . Books ship from the US and Ireland.
-
Anticancer Drug Development Guide
Book 22 of 96: Cancer Drug Discovery and DevelopmentSeller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Seller rating 5 out of 5 stars
Condition: New. Provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included material on the use of high throughput screening in industry, and on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations. Editor(s): Teicher, Beverly A.; Andrews, Paul. Series: Cancer Drug Discovery and Development. Num Pages: 451 pages, 161 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 25. Weight in Grams: 2260. . 2004. 2 Rev ed. Hardback. . . . .
-
Condition: New. This unique volume traces the critically important pathway by which a molecule becomes an anticancer agent. The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink m.
-
Condition: New. Provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included material on the use of high throughput screening in industry, and on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations. Editor(s): Teicher, Beverly A.; Andrews, Paul. Series: Cancer Drug Discovery and Development. Num Pages: 451 pages, 161 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 25. Weight in Grams: 2260. . 2004. 2 Rev ed. Hardback. . . . . Books ship from the US and Ireland.
-
Condition: New. pp. 468 Index 1st Edition.
-
Condition: New. pp. 468 68:B&W 7 x 10 in or 254 x 178 mm Case Laminate on White w/Gloss Lam.
-
Condition: New. pp. 468.
-
Anticancer Drug Development Guide : Preclinical Screening, Clinical Trials, and Approval
Book 22 of 96: Cancer Drug Discovery and DevelopmentLanguage: English
Published by Humana Press Feb 2004, 2004
ISBN 10: 1588292282 ISBN 13: 9781588292285
Buch. Condition: Neu. Neuware - This unique volume traces the critically important pathway by which a 'molecule' becomes an 'anticancer agent. ' The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink malignant tumor masses for relatively substantial periods of time gave great impetus to the search for molecules that would be lethal to specific cancer cells. Weare still actively engaged in that search today. The question is how to discover these 'anticancer' molecules. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Second Edition describes the evolution to the present of preclinical screening methods. The National Cancer Institute's high-throughput, in vitro disease-specific screen with 60 or more human tumor cell lines is used to search for molecules with novel mechanisms of action or activity against specific phenotypes. The Human Tumor Colony-Forming Assay (HTCA) uses fresh tumor biopsies as sources of cells that more nearly resemble the human disease. There is no doubt that the greatest successes of traditional chemotherapy have been in the leukemias and lymphomas. Since the earliest widely used in vivo drug screening models were the murine L 1210 and P388 leukemias, the community came to assume that these murine tumor models were appropriate to the discovery of 'antileukemia' agents, but that other tumor models would be needed to discover drugs active against solid tumors.
